Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Heryi Pharmaceutical Logo
Heryi Pharmaceutical Growth Score
33
CB Rank
2729086
Heat Score
14
Heryi Pharmaceutical produces and sells pharmaceutical intermediates, raw materials, and related products.
Founded
obfuscation
PublicPost-IPO Equity Tianchang, Anhui, China251-500 www.heryipharma.com/
Chemical
Manufacturing
Pharmaceutical
Overview

Heryi Pharmaceutical
Total Funding
obfuscation
Growth Score
33
Heat Score
14

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score33
-2 pts
in past quarter
Heat Score 14
13 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About Heryi Pharmaceutical

CB Rank
2729086
Heryi Pharmaceutical produces and sells pharmaceutical intermediates, raw materials, and related products.
Founded
obfuscation
PublicPost-IPO Equity Tianchang, Anhui, China251-500 www.heryipharma.com/
Chemical
Manufacturing
Pharmaceutical

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Angel
OBF
in
obfuscation

Details

Legal Name Anhui Heryi Pharmaceutical Co., Ltd.
Also Known As 峆一药业, 安徽峆一药业股份有限公司, Heyi Yaoye
Operating Status Active
Stock Symbol  NEEQ:430478
Company Type For Profit
About the Company
Heryi Pharmaceutical engages in the manufacture and sale of pharmaceutical intermediates, raw materials, and related products. Their product categories include anti-allergic, antithrombotic, antioxidant, gastric ulcer, antiviral, pain, UV absorbers, and more.
Phone Number 0550-7711888
Contact Email ceo@heryipharma.com
Predictions & Insights

Products & Services

Prulifloxacin
An antibiotic used to treat bacterial infections by inhibiting bacterial DNA gyrase and topoisomerase IV.
Sitagliptin Phosphate
A pharmaceutical compound used as an active ingredient in medications for managing type 2 diabetes by regulating blood sugar levels.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Heryi Pharmaceutical Logo
Post-IPO Equity - Heryi Pharmaceutical
3
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Heryi Pharmaceutical Logo
Post-IPO Equity - Heryi Pharmaceutical
3
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Heryi Pharmaceutical Logo
Post-IPO Equity - Heryi Pharmaceutical
3
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Heryi Pharmaceutical Logo
Post-IPO Equity - Heryi Pharmaceutical
3
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Heryi Pharmaceutical Logo
Post-IPO Equity - Heryi Pharmaceutical
3
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Heryi Pharmaceutical Logo
Post-IPO Equity - Heryi Pharmaceutical
3
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Heryi Pharmaceutical Logo
Post-IPO Equity - Heryi Pharmaceutical
3
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Heryi Pharmaceutical Logo
Post-IPO Equity - Heryi Pharmaceutical
3
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Heryi Pharmaceutical Logo
Post-IPO Equity - Heryi Pharmaceutical
3
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Heryi Pharmaceutical Logo
Post-IPO Equity - Heryi Pharmaceutical
3
obfuscation
— Post-IPO Equity

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 251-500
News
Technology
View Tech Report

Monthly Web Visits

1,414
200.85%
 in past month

Active Website Tech Count

6Heryi Pharmaceutical is actively using 6 technologies for its website, according to BuiltWith. These include Euro, CommonCrawl Top 10m, and  Pound Sterling.

Total IP

1Heryi Pharmaceutical has 1 registered patent in the 'Organic Chemistry' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Heryi Pharmaceutical's headquarters? Heryi Pharmaceutical is located in Tianchang, Anhui, China.Who invested in Heryi Pharmaceutical? Heryi Pharmaceutical has 4 investors including Nanjing Securities and  Industrial Securities.When was the last funding round for Heryi Pharmaceutical? Heryi Pharmaceutical closed its last funding round on
obfuscation
from a Post-IPO Equity round.How much funding has Heryi Pharmaceutical raised to date? Heryi Pharmaceutical has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8fe006b 1)
|